 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, February 14, 2007, 27(7):1511-1518; doi:10.1523/JNEUROSCI.4391-06.2007
Previous Article | Next Article
Development/Plasticity/Repair
Matrix Metalloproteinase-9 Gene Knock-out Protects the Immature Brain after Cerebral Hypoxia–Ischemia
Pernilla Svedin,1 Henrik Hagberg,2 Karin Sävman,2 Changlian Zhu,3,4 andCarina Mallard1 Departments of 1Neuroscience and Physiology and 2Clinical Sciences, Perinatal Center, Sahlgrenska Academy, and 3Center for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, Göteborg University, 405 30 Göteborg, Sweden, and 4Department of Pediatrics, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Abstract
Top
Abstract
Introduction
Inhibition of matrix metalloproteinase-9 (MMP-9) protects the adult brain after cerebral ischemia. However, the role of MMP-9 in the immature brain after hypoxia–ischemia (HI) is unknown. We exposed MMP-9(–/–) [MMP-9 knock-out (KO)] and wild-type (WT) mice to HI on postnatal day 9. HI was induced by unilateral ligation of the left carotid artery followed by hypoxia (10% O2; 36°C). Gelatin zymography showed that MMP-9 activity was transiently increased at 24 h after HI in the ipsilateral hemisphere and MMP-9-positive cells were colocalized with activated microglia. Seven days after 50 min of HI, cerebral tissue volume loss was reduced in MMP-9 KO (21.8 ± 1.7 mm3; n = 22) compared with WT (32.3 ± 2.1 mm3; n = 22; p < 0.001) pups, and loss of white-matter components was reduced in MMP-9 KO compared with WT pups (neurofilament: WT, 50.9 ± 5.4%; KO, 18.4 ± 3.1%; p < 0.0001; myelin basic protein: WT, 57.5 ± 5.8%; KO, 23.2 ± 3.5%; p = 0.0001). The neuropathological changes were associated with a delayed and diminished leakage of the blood–brain barrier (BBB) and a decrease in inflammation in MMP-9-deficient animals. In contrast, the neuroprotective effects after HI in MMP-9-deficient animals were not linked to either caspase-dependent (caspase-3 and cytochrome c) or caspase-independent (apoptosis-inducing factor) processes. This study demonstrates that excessive activation of MMP-9 is deleterious to the immature brain, which is associated with the degree of BBB leakage and inflammation. In contrast, apoptosis does not appear to be a major contributing factor.
Key words: neonatal; inflammation; cerebral palsy; apoptosis; caspase; extracellular matrix
Introduction
Matrix metalloproteinase-9 (MMP-9; gelatinase B) belongs to a subgroup of gelatinases in the family of zinc-dependent extracellular peptidases, so-called matrix metalloproteinases, that are able to modify components of the extracellular matrix (Yong et al., 1998). MMP-9 is important for normal brain development but can be harmful when activated under pathological conditions (Van den Steen et al., 2002
MMP-9 has been shown to degrade collagen type IV in the basement membranes of endothelial walls, which may lead to disruption of the blood–brain barrier (BBB) after both cerebral ischemia and inflammation, allowing entry of leukocytes or cytokines into the brain (Rosenberg et al., 1994
There is also evidence to suggest that MMPs are involved in regulation of intracellular proteolytic cascades. MMPs, including MMP-9, may regulate inflammatory processes, because it has been shown to process proinflammatory cytokines such as interleukin-1ß (IL-1ß) into its biologically active and mature form (Schonbeck et al., 1998
The pathogenesis of brain injury is age dependent and particularly inflammatory, and caspase-dependent processes appear to be important in the immature brain (Vannucci and Hagberg, 2004
Materials and Methods
Induction of HI in postnatal day 9 mice
MMP-9(–/–) and wild-type (WT) animals were bred from C57BL/6 heterozygote mice (Vu et al., 1998HI was induced on postnatal day 9 (P9) as described previously (Rice et al., 1981
Genotyping: DNA preparation and PCR
The genotype of the mice was determined by PCR analysis of DNA that was extracted from the tail. Approximately 2 mm of tissue was digested in buffer (50 mM Tris-HCl, pH 8.0, 100 mM EDTA, 100 mM NaCl, and 1% SDS) containing 1 mg/ml proteinase-K (Roche Diagnostics, Penzberg, Germany) overnight at 60°C. To extract the DNA, one-half the original volume of potassium acetate, 5 M, was added, and the mixture was centrifuged at 13,000 rpm for 20 min. The supernatant was saved and mixed with double the original volume of 100% ethanol and incubated at –20°C for at least 30 min. To precipitate the DNA, the mixture was centrifuged at 13,000 rpm for 25 min at 4°C. Pellets were washed with 75% ethanol and left to dry after removal of the liquid. The DNA was dissolved in 50 µl of sterile H2O.Two microliters of the extracted DNA were added to the reaction mixture [1x PCR buffer (250 mM Tris-HCl, pH 8.3, 375 mM KCl, 15 mM MgCl2; Sigma-Aldrich, St. Louis, MO), 200 µM dNTP, 0.5 µM Primer 1-4, and 0.04 U/µl Taq polymerase (Sigma-Aldrich)], which had a total volume of 25 µl. The primers (Cybergene, Huddinge, Sweden) that were used showed the WT (5'-ATG ATT GAA CAA GAT GGA TTG CAC G-3', 5'-TTC GTC CAG ATC ATC CTG ATC GAC-3') band of 300 bp, the MMP-9-deficient (5'-GCA TAC TTG TAC CGC TAT GG-3', 5'-TAA CCG GAG GTG CAA ACT GG-3') band of 480 bp, or the heterozygote mice that showed both bands (see Fig. 1A). The reaction consisted of 32 cycles: denaturation, 94°C, 45 s; annealing, 60°C, 45 s; elongation, 72°C, 1 min 30 s. The PCR products were analyzed by using Tris-borate-EDTA buffer agarose electrophoresis (1.5%) labeled with ethidium bromide. The bands were visualized by using a LAS-100 cooled CCD camera (Fujifilm, Tokyo, Japan).
View larger version (63K):
[in this window]
[in a new window]
Figure 1. A, The band of 480 bp corresponds to the MMP-9 gene KO mice, and the band of 300 bp represents the MMP-9 gene in WT mice. Heterozygote (hetz) animals express both the 480 and 300 bp fragments. B, C, Gelatin zymograms show MMP-9 (105 kDa) weakly expressed at 6 h (B) and strongly at 24 h (C) after HI in the ipsilateral hemisphere in WT animals. No MMP-9 activity was seen in the contralateral hemisphere or in MMP-9 KO animals. MMP-2 activity (72 kDa) was observed in all animals.
Gelatin zymography
To confirm the activation of MMP-9, gelatin zymography was performed at 1, 3, 6, 24, and 72 h after 60 min HI. Pups (n = 3 per time point) were killed with an overdose of thiopental (pentothal sodium, intraperitoneally) and perfused with cold saline, and the brains were rapidly removed and divided into an ipsilateral ischemic hemisphere and a contralateral nonischemic hemisphere. Control animals, 9 and 12 d old (n = 3 per time point), were treated in the same way as the HI animals. Hemispheric tissue was frozen immediately in isopentane and stored at –80°C.The frozen brain samples were homogenized and solubilized in 0.5% Triton X-100 in PBS, pH 7.0, for 24 h at 4°C. The homogenate was centrifuged at 13,000 rpm for 10 min at 4°C. Total protein concentration in the supernatants was measured by Soft Max PRO 3.0.
The samples were mixed with one-part 2x Tris-glycine SDS sample buffer [12.5 mM Tris–0.5 M HCl, pH 6.8, 20% glycerol, 4% SDS (w/v), and 0.005% bromophenol blue (w/v)], and the mixtures were left at room temperature for 10 min. The samples (20 µl/well) were applied on a 10% polyacrylamide gel containing 0.1% gelatin, and the gel was electrophoresed with 1x Tris-glycine SDS electrode buffer (25 mM TrizmaBase, 190 mM glycin, and 3.5 mM SDS) according to standard running conditions. After running, the gel was first incubated with zymogram renaturing buffer [2.5% Triton X-100 (v/v)] with gentle agitation for 30 min at room temperature. Then the gel was incubated in fresh zymogram renaturing buffer overnight at 37°C for maximum sensitivity. Coomassie blue R-250 (0.5%; w/v) in fixative [methanol/acetic acid/water (50:10:40)] was used for visualizing the areas of protease activity, followed by destaining [methanol/acetic acid/water (50:10:40)]. Human MMP-9 and MMP-2 (Millipore, Bedford, MA) were used as standards.
Immunohistochemical procedures
Immunohistochemistry was performed as described previously (Zhu et al., 2000The following primary antibodies and dilutions were used: mouse monoclonal anti- microtubule-associated protein-2 (MAP-2; 1:2000, M4403; Sigma-Aldrich); mouse monoclonal anti-MBP (1:10,000, SMI 94; Sternberger Monoclonal, Lutherville, MD); mouse monoclonal anti-phosphorylated neurofilaments (NFs; 1:2000, SMI312; Sternberger Monoclonal); goat polyclonal anti-apoptosis inducing factor (AIF; 1:100, sc-9416; Santa Cruz Biotechnology, Santa Cruz, CA); mouse monoclonal anti-cytochrome c (1:400, 556433) and rabbit polyclonal anti-active caspase-3 (1:50, 557035) (both from BD Biosciences PharMingen, San Diego, CA); and polyclonal anti-MMP-9 (1:10,000, ab16306) and polyclonal anti-laminin (1:250, ab11575) (both from Abcam, Cambridge, UK). Nuclear staining was performed with 1 µg/ml 4'-6-diamidino-2-phenylindole (DAPI; Invitrogen, San Diego, CA) in PBS for 5 min at room temperature with gentle agitation.
Microglia cells were visualized by Griffonia simplicifolia isolectin-B4 (10 µg/ml), which was horseradish peroxidase (L5391; Sigma-Aldrich) and DAB labeled.
Neuropathological outcome
Brain injury evaluation. The pups were killed on P16 for evaluation of brain infarction. Animals were anesthetized with thiopental (pentothal sodium) and perfusion fixed with 5% paraformaldehyde (Histofix; Histolab, Göteborg, Sweden), and the brains were dehydrated and embedded in paraffin. Evenly spaced coronal sections (5 µm) throughout the brain were stained with MAP-2, which labels neurons and dendrites. Microscope images were captured by a CCD camera (DP50; Olympus Optical, Tokyo, Japan), and the area of MAP-2-positive staining in each hemisphere was measured (MicroImage, version 4.0; Olympus Optical). The MAP-2-positive area in the ipsilateral hemisphere was subtracted from the contralateral hemisphere for each brain level and expressed as the percentage of tissue loss of the contralateral hemisphere. The total volume of tissue loss was calculated according to the Cavalieri Principle, in which the area of tissue loss at each level was calculated by subtracting the MAP-2-positive area in the ipsilateral area from the contralateral hemisphere. The following formula was used: V =A x P x T, where V is the total volume,
White-matter damage. The loss of white matter was measured immunohistochemically by the presence of MBP and NF on P16 in sections at the striatum and hippocampal levels, as demonstrated previously (Hedtjarn et al., 2002
Inflammation
Microglial cells in the injured hemisphere at the hippocampal level were detected by isolectin histochemistry at 6 h, 24 h, and 7 d after the HI insult. The number of activated microglial cells were estimated (at 20x magnification) in the cerebral cortex, subcortical white matter, hippocampus, and thalamus according to the following scale: 0 = 0 microglia cells; 1 = 1–25 cells; 2 = 26–50 cells; 3 = 51–75 cells; 4 = >75 cells.General cell death and apoptotic markers
Both caspase-dependent and -independent pathways of cell death were investigated by immunohistochemical staining of AIF (6 h after HI), cytochrome c (6 h after HI), and caspase-3 (24 h after HI). AIF-, cytochrome c-, and caspase-3-positive cells were counted within a predetermined field (0.078 mm2) in the ipsilateral hemisphere at the hippocampal level at 400x magnification in the cerebral cortex and the hippocampus. Cells in four fields per brain region were counted and expressed as the mean number of cells per square millimeters. General cell death was investigated according to morphological hallmarks of cell death by examining DAPI nuclear staining. The number of cells with DNA damage were counted in the penumbra of the cerebral cortex in four visual fields per animal (each field was 0.324 mm2) and expressed as the mean number of cells per square millimeters.Cellular immunoreactivity of MMP-9
The immunohistochemical presence of MMP-9 was determined in different brain regions at 0, 1, 3, 6, 24, and 72 h after HI in WT animals. MMP-9 KO mice were used as negative controls. The cellular localization of MMP-9 was determined by double labeling to microglia (10 µl/ml FITC-labeled isolectin B4, L2895; Sigma-Aldrich), astrocytes (monoclonal anti-GFAP, 1:250, G3893; Sigma-Aldrich), and neurons (monoclonal anti-neuronal nuclei, 1:250, MAB377; Millipore). FITC-conjugated avidin (25 µl/ml) or Texas Red-conjugated avidin (25 µl/ml) (Invitrogen) was used after incubation with biotinylated secondary antibody.BBB permeability
At 0, 1, 3, 6, 24, and 72 h after the HI insult, pups (n = 3 per time point) were killed with an overdose of thiopental (pentothal sodium) intraperitoneally and perfusion fixed with 5% paraformaldehyde, followed by 4 h postfixation and incubation in 20% sucrose in 0.1 M PBS solution. Free-floating sections (80 µm) were incubated with biotinylated horse anti-mouse IgG (1:250 in PBS; Vector Laboratories). Immunoreactivity was visualized as described above. The immunohistochemical presence of laminin, a structural component of the BBB, was determined in the hippocampus 24 h after HI. The hippocampus in each hemisphere was outlined at low magnification (1.5x) in each animal. Using stereological principles (Stereoinvestigator; MicroBrightField, Colchester, VT), 20 counting frames (50 x 50 µm) were randomly positioned within the hippocampus at equal distance from each other, and the number of laminin-positive profiles within each counting frame was determined at high magnification (63x).Statistics
Statistical analysis was performed using GraphPad Prism 4 software (GraphPad Software, San Diego, CA). The Mann–Whitney nonparametric ranking test or unpaired t test was used for statistical comparisons between study groups. Values were considered significant at p < 0.05, and data are presented as mean ± SEM.
Results
MMP activity after HI
The genotype of the animals was confirmed by PCR, with KO mice demonstrating a band at 480 bp and WT mice demonstrating a band at 300 bp (Fig. 1A). No MMP-9 activity could be observed in MMP-9-deficient animals after HI, as confirmed by gelatin zymography (Fig. 1B). A weak expression of MMP-9 was seen 6 h after HI in the ipsilateral hemisphere in WT animals (Fig. 1B). At 24 h after HI, there was a marked increase in MMP-9 (Fig. 1C) and to a lesser extent at 72 h after HI (data not shown). Relatively low expression of the proenzyme of MMP-2 (72 kDa) was seen in the contralateral and ipsilateral hemispheres in both WT and MMP-9 KO animals at all time points after HI (Fig. 1B,C).MMP-9 immunoreactivity after HI
Very few MMP-9-positive cells, in either the ipsilateral or the contralateral hemisphere, could be detected in the brain at 0, 1, 3, and 6 h after the insult. After 24 h, an increase in cells expressing MMP-9 was observed in the hippocampus, thalamus, striatum, and cerebral cortex in the ipsilateral hemisphere (Fig. 2A). The highest density of MMP-9-positive cells was observed in the thalamus, with fewer cells in the cerebral cortex and hippocampus. By 72 h after HI, only a few positive MMP-9-positive cells were observed. No MMP-9-positive cells were found in the MMP-9 KO animals (Fig. 2B).
View larger version (75K):
[in this window]
[in a new window]
Figure 2. A, B, MMP-9-positive cells in the thalamus in WT (A) and MMP-9 KO (B) animals 24 h after HI. C, D, F, G, I, J, The cellular localization of MMP-9 immunoreactivity (C, F, I) was determined by double labeling for microglial cells (isolectin) (D), astrocytes (GFAP) (G), and neurons [NeuN (neuronal-specific nuclear protein)] (J) 24 h after HI. E, H, K, MMP-9 was colocalized with activated microglia (E) but not with astrocytes (H) or neurons (K).
Double-labeling experiments showed that the MMP-9 expression was colocalized with microglia cells (isolectin-positive cells) (Fig. 2C–E) but not with neurons or astrocytes (Fig. 2F–K).Neuropathological outcome
Brain injury evaluation
Brain injury was more severe in animals exposed to 60 min HI (Fig. 3A,B) compared with 50 min HI (Fig. 3C,D). Brain injury in the ipsilateral compared with the contralateral hemisphere at 14 evenly spaced brain levels was determined in MAP-2-stained sections. In animals that were exposed to 60 min of HI, there was no significant difference in brain injury between MMP-9 KO (n = 18) and WT (n = 19) mice at any of the brain levels examined (Fig. 3A,B,E), and there was no difference in the total volume of tissue loss between groups (WT, 38.6 ± 2.0 mm3; KO, 38.4 ± 2.0 mm3; p = 0.9636) (Fig. 3G). In contrast, there was reduction in brain injury in MMP-9 KO animals at 13 of 14 brain levels (Fig. 3F) and in the total loss of tissue volume (21.8 ± 1.7 mm3; n = 22) compared with WT animals (32.3 ± 2.1 mm3; n = 22) after 50 min of HI (p = 0.0006) (Fig. 3G).
View larger version (44K):
[in this window]
[in a new window]
Figure 3. A–D, Immunohistochemical staining for MAP-2 in WT (A, C) and MMP-9 KO (B, D) animals 7 d after HI. Animals exposed to 60 min of HI (A, B) exhibit more severe brain injury compared with pups that were exposed to 50 min of HI (C, D). E, F, Quantification of brain tissue loss based on MAP-2 staining at different brain levels after HI (posterior anterior part of the brain). Tissue loss was reduced at 13 of 14 brain levels in MMP-9 KO after 50 min HI (F) but not after 60 min HI (E). G, Total brain tissue loss (cubed millimeters) was reduced in MMP-9 KO after 50 min HI but not 60 min HI. Error bars indicate mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001 compared with WT.
White-matter damage
Injury to the subcortical white matter was examined 1 week after the HI insult by immunohistochemical analysis of the white-matter markers MBP and NF (Fig. 4A–D). A significant preservation of both NF and MBP was observed in the moderately injured group (NF: WT, 50.9 ± 5.4%; KO, 18.4 ± 3.1%; p < 0.0001; MBP: WT, 57.5 ± 5.8%; KO, 23.2 ± 3.5%; p = 0.0001) (Fig. 4E,F). In contrast, no differences were observed in the loss of white-matter markers in the severely damaged group (NF: WT, 74.6 ± 4.8%; KO, 69.8 ± 5.4%; p = 0.5136; MBP: WT, 72.9 ± 4.2%; KO, 68.2 ± 4.5%; p = 0.4752) (Fig. 4E,F).
View larger version (46K):
[in this window]
[in a new window]
Figure 4. A–D, White-matter injury was determined by the loss of MBP (A, B) and NF (C, D) in WT (A, C) and MMP-9 KO (B, D) animals 7 d after HI. E, F, After 50 min HI, MMP-9 KO animals demonstrated preservation of MBP (E) and NF (F) compared with WT but not after 60 min HI (E, F). Immunohistochemical staining showed loss of MBP and NF in the ipsilateral hemisphere in WT animals compared with MMP-9 KO animals (B, D). Error bars indicate mean ± SEM. ***p < 0.001 compared with WT.
BBB permeability
BBB permeability was investigated immunohistochemically by the presence of IgG (Muramatsu et al., 1997
View larger version (49K):
[in this window]
[in a new window]
Figure 5. The integrity of the BBB was evaluated by histochemical analysis of IgG and laminin immunoreactivity at 24 h (A, B, E–I) and 72 h (C, D) after HI (n = 3 per group). A–D, In WT animals (A, C), the BBB was disrupted at both 24 and 72 h, whereas in the MMP-9-KO animals, the BBB opened only transiently at 24 h after HI (B) and was almost intact at 72 h after HI (D). E–I, Furthermore, there was a reduction in laminin-positive staining in the ipsilateral hemisphere (E, I) compared with the contralateral hemisphere (F, I) in WT animals, which was not seen in KO animals (G–I). **p < 0.01.
Because neuropathological analysis of gray and white matter and BBB examination indicated that there were no differences between MMP-9 KO and WT animals after 60 min HI, only animals subjected to 50 min HI were analyzed further.Inflammation
Microglial activation was evaluated in sections at the hippocampal level at 6 h, 24 h, and 7 d after HI. Very few activated microglia cells were observed 6 h after HI (Fig. 6A), with a more robust inflammatory response at 24 h (Fig. 6B). There was no difference in any brain region investigated between MMP-9 KO and WT groups at either 6 or 24 h (Fig. 6A,B). In contrast, a significant attenuation in microglial activation was observed 7 d after HI in MMP-9 KO mice compared with WT animals (Fig. 6C).
View larger version (16K):
[in this window]
[in a new window]
Figure 6. Analysis of activated microglia at the hippocampal level at 6 h (A), 24 h (B), and 7 d (C) after HI. In MMP-9 KO animals, there was increased microglia activation 7 d after HI in the hippocampus, white matter (WM), and cortex (C). Error bars indicate mean ± SEM. *p < 0.05; **p < 0.01.
General cell death and apoptotic markers
Cell death, as shown by DAPI staining, was reduced in KO animals at 24 h and 7 d after HI (Fig. 7A–E). The apoptotic markers AIF, cytochrome c, and caspase-3 were investigated 6 h (AIF and cytochrome c) and 24 h (caspase-3) after HI (n = 8 animals/group). Apart from a decrease in cytochrome c-positive cells in the CA1/2 area of the hippocampus in MMP-9 KO animals (Fig. 7G), there were no alterations in apoptotic markers in the hippocampus or cortex (Fig. 7F–H). To also confirm neuroprotection in these animals, tissue loss was determined in MAP-2-stained sections at 24 h after HI, which showed a 26% reduction in injury in KO animals (26.9 ± 2%; n = 8) compared with WT (36.3 ± 4%; n = 8; p < 0.05).
View larger version (29K):
[in this window]
[in a new window]
Figure 7. A–D, Photomicrographs of DAPI staining at 24 h (A, B) and 7d (C, D) after HI in WT (A, C) and KO (B, D) animals. E, There was a reduction in the number of DNA-damaged cells in KO animals at both 24 h and 7d after HI (E). F–H, Cells positive for AIF (F) and cytochrome c (G) 6 h after HI and caspase-3 (H) 24 h after HI were determined immunohistochemically at the hippocampal level of the brain. Error bars indicate mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; n = 8 per group.
Discussion
This study shows that deletion of the MMP-9 gene reduces cerebral tissue volume loss, protects the white matter, and attenuates inflammation in the immature brain after a moderate HI insult. The neuroprotection is also associated with a delayed and reduced opening of the BBB. However, although general cell death is attenuated, neuroprotection after MMP-9 deficiency does not appear to be linked to either caspase-dependent or -independent apoptotic mechanisms.Neuroprotection after inhibition of MMP-9 activation has been demonstrated previously in the adult brain after focal cerebral ischemia in both the mouse and rat, either by using MMP-9-deficient animals or MMP-9 inhibitors (Romanic et al., 1998
In addition to the reduction in tissue loss, the injury to MBP and NFs was also attenuated in MMP-9-deficient animals, which is similar to studies of focal cerebral ischemia in adult MMP-9 gene KO mice that show reduced damage to white-matter components (Asahi et al., 2001
It has been suggested that MMP-2 may play a role in the development of brain injury because the function of MMP-2 is similar to MMP-9; however, no effect has been reported on brain injury in adult MMP-2 KO mice after focal ischemia (Asahi et al., 2001
The neuroprotection in MMP-9 KO animals after moderate HI was associated with a shorter period of BBB opening compared with either 50 min HI in WT animals or 60 min HI in WT and MMP-9 KO mice. These results may suggest that the length of BBB opening after HI plays an important role in the brain injury. Particularly, the BBB opening in immature animals has been linked to the severity of injury (Muramatsu et al., 1997
According to the gelatin zymography results in the present study, MMP-9 activation in the ipsilateral hemisphere was observed 24 h after HI, which is similar to the time frame of MMP-9 activation previously observed in adult animals after ischemia (Wang et al., 2000
MMP-9-immunopositive cells have been detected previously in neurons, glia cells, and blood vessels 48 h after transient middle cerebral artery occlusion in adult rats (Rosenberg et al., 2001
The localization of MMP-9 in activated microglia cells suggests that inflammatory mechanisms may be involved in brain injury, which is in agreement with our previous study demonstrating a profound inflammatory response after HI in neonatal mice (Hedtjarn et al., 2004
In the adult, MMPs have been implicated in several cerebrovascular diseases, in which degradation of components of the extracellular matrix, including degradation of collagen type IV, have been identified as a deleterious response (Fatar et al., 2005
In conclusion, this study demonstrates that MMP-9 plays an important role in the development of hypoxic–ischemic injury in the immature brain. The neuroprotective effects of MMP-9 appear to be related to inflammatory processes rather than apoptosis.
Footnotes
Received Oct. 9, 2006; revised Dec. 18, 2006; accepted Jan. 2, 2007.This work was supported by Swedish government grants to researchers in public service (ALFGBG-2863), the Swedish Research Council (K2004-33X-14185-03A and VR2003-4155), the Laerdal Foundation, the Åhlen Foundation, the Sven Jerring Foundation, the Wilhelm and Martina Lundgren Foundation, and the Frimurare Barnhus Foundation, Göteborg Medical Society. We thank Josefin Caous for her excellent technical assistance.
Correspondence should be addressed to Dr. Carina Mallard, Perinatal Center, Department of Neuroscience and Physiology, Sahlgrenska Academy, Göteborg University, P.O. Box 432, 405 30 Göteborg, Sweden. Email: carina.mallard{at}gu.se
Copyright © 2007 Society for Neuroscience 0270-6474/07/271511-08$15.00/0
References
Anthony DC, Bolton SJ, Fearn S, Perry VH (1997) Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 120:435–444.
[Abstract/Free Full Text] Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, Banda MJ (1990) Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50:2322–2329.
[Abstract/Free Full Text] Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20:1681–1689.[CrossRef][ISI][Medline]
Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood–brain barrier and white matter components after cerebral ischemia. J Neurosci 21:7724–7732.
[Abstract/Free Full Text] Colton CA, Keri JE, Chen WT, Monsky WL (1993) Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation. J Neurosci Res 35:297–304.[CrossRef][ISI][Medline]
Copin JC, Goodyear MC, Gidday JM, Shah AR, Gascon E, Dayer A, Morel DM, Gasche Y (2005) Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice. Eur J Neurosci 22:1597–1608.[CrossRef][ISI][Medline]
Cuzner ML, Gveric D, Strand C, Loughlin AJ, Paemen L, Opdenakker G, Newcombe J (1996) The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J Neuropathol Exp Neurol 55:1194–1204.[ISI][Medline]
Fatar M, Stroick M, Griebe M, Hennerici M (2005) Matrix metalloproteinases in cerebrovascular diseases. Cerebrovasc Dis 20:141–151.[ISI][Medline]
Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, Chan PH, Park TS (2005) Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 289:H558–H568.
[Abstract/Free Full Text] Gottschall PE, Deb S (1996) Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3:69–75.[CrossRef][ISI][Medline]
Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY, Lipton SA (2005) A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 25:6401–6408.
[Abstract/Free Full Text] Harkness KA, Adamson P, Sussman JD, Davies-Jones GA, Greenwood J, Woodroofe MN (2000) Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123:698–709.
[Abstract/Free Full Text] Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H (2002) Interleukin-18 involvement in hypoxic–ischemic brain injury. J Neurosci 22:5910–5919.
[Abstract/Free Full Text] Hedtjarn M, Mallard C, Hagberg H (2004) Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab 24:1333–1351.[CrossRef][ISI][Medline]
Hedtjarn M, Mallard C, Iwakura Y, Hagberg H (2005) Combined deficiency of IL-1beta18, but not IL-1alphabeta, reduces susceptibility to hypoxia-ischemia in the immature brain. Dev Neurosci 27:143–148.[CrossRef][ISI][Medline]
Jiang X, Namura S, Nagata I (2001) Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci Lett 305:41–44.[CrossRef][ISI][Medline]
Lefebvre V, Peeters-Joris C, Vaes G (1991) Production of gelatin-degrading matrix metalloproteinases ("type IV collagenases") and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha. Biochim Biophys Acta 1094:8–18.[Medline]
Liu XH, Kwon D, Schielke GP, Yang GY, Silverstein FS, Barks JD (1999) Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab 19:1099–1108.[CrossRef][ISI][Medline]
Lohmann C, Krischke M, Wegener J, Galla HJ (2004) Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Brain Res 995:184–196.[CrossRef][ISI][Medline]
Maeda A, Sobel RA (1996) Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 55:300–309.[ISI][Medline]
Mannello F, Luchetti F, Falcieri E, Papa S (2005) Multiple roles of matrix metalloproteinases during apoptosis. Apoptosis 10:19–24.[CrossRef][ISI][Medline]
McRae A, Gilland E, Bona E, Hagberg H (1995) Microglia activation after neonatal hypoxic-ischemia. Brain Res Dev Brain Res 84:245–252.[CrossRef][Medline]
Mun-Bryce S, Rosenberg GA (1998) Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol 274:R1203–R1211.
Muramatsu K, Fukuda A, Togari H, Wada Y, Nishino H (1997) Vulnerability to cerebral hypoxic-ischemic insult in neonatal but not in adult rats is in parallel with disruption of the blood-brain barrier. Stroke 28:2281–2288. discussion 2288–2289.
Okada Y, Tsuchiya H, Shimizu H, Tomita K, Nakanishi I, Sato H, Seiki M, Yamashita K, Hayakawa T (1990) Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun 171:610–617.[CrossRef][ISI][Medline]
Rice JE III, Vannucci RC, Brierley JB (1981) The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9:131–141.[CrossRef][ISI][Medline]
Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020–1030.
[Abstract/Free Full Text] Rosenberg GA, Dencoff JE, McGuire PG, Liotta LA, Stetler-Stevenson WG (1994) Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab Invest 71:417–422.[ISI][Medline]
Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, Grossetete M, Razhagi A, Miller K, Gearing A (2001) Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893:104–112.[CrossRef][ISI][Medline]
Saren P, Welgus HG, Kovanen PT (1996) TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 157:4159–4165.[Abstract]
Schonbeck U, Mach F, Libby P (1998) Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 161:3340–3346.
[Abstract/Free Full Text] Sellebjerg F, Sorensen TL (2003) Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain Res Bull 61:347–355.[CrossRef][ISI][Medline]
Silverstein FS, Barks JD, Hagan P, Liu XH, Ivacko J, Szaflarski J (1997) Cytokines and perinatal brain injury. Neurochem Int 30:375–383.[CrossRef][ISI][Medline]
Svedin P, Kjellmer I, Welin AK, Blad S, Mallard C (2005) Maturational effects of lipopolysaccharide on white-matter injury in fetal sheep. J Child Neurol 20:960–964.[ISI][Medline]
Uhm JH, Dooley NP, Oh LY, Yong VW (1998) Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 22:53–63.[CrossRef][ISI][Medline]
Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37:375–536.[CrossRef][ISI][Medline]
Vannucci SJ, Hagberg H (2004) Hypoxia-ischemia in the immature brain. J Exp Biol 207:3149–3154.
[Abstract/Free Full Text] Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411–422.[CrossRef][ISI][Medline]
Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, Dixon CE, Fini ME, Lo EH (2000) Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 20:7037–7042.
[Abstract/Free Full Text] Wheeler RD, Boutin H, Touzani O, Luheshi GN, Takeda K, Rothwell NJ (2003) No role for interleukin-18 in acute murine stroke-induced brain injury. J Cereb Blood Flow Metab 23:531–535.[ISI][Medline]
Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21:75–80.[CrossRef][ISI][Medline]
Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, Wang X, Lo EH (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12:441–445.[CrossRef][ISI][Medline]
Zhu C, Wang X, Hagberg H, Blomgren K (2000) Correlation between caspase-3 activation and three different markers of DNA damage in neonatal cerebral hypoxia-ischemia. J Neurochem 75:819–829.[CrossRef][ISI][Medline]
Zhu C, Wang X, Xu F, Bahr BA, Shibata M, Uchiyama Y, Hagberg H, Blomgren K (2005) The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 12:162–176.[CrossRef][ISI][Medline]
This article has been cited by other articles:
F. Adhami, D. Yu, W. Yin, A. Schloemer, K. A. Burns, G. Liao, J. L. Degen, J. Chen, and C.-Y. Kuan
Deleterious Effects of Plasminogen Activators in Neonatal Cerebral Hypoxia-Ischemia
Am. J. Pathol., June 1, 2008; 172(6): 1704 - 1716.
[Abstract] [Full Text] [PDF]
This Article Abstract 
Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager 
Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Svedin, P. Articles by Mallard, C. Search for Related Content PubMed PubMed Citation Articles by Svedin, P. Articles by Mallard, C.
|
|
|
|
 |
|